Imagine Healthcare
- Ketamine Therapy
- Migraine Treatment
- Psychedelic Therapy
Read the Psychedelic Therapy guide for the educational context behind this treatment category.
Chicago, IL
Searching for psychedelic medicine in Chicago, Illinois often leads to ketamine-based care in physician offices and infusion suites. Psychedelic therapy is a broad directory category, so confirm whether an office provides ketamine infusions, ketamine-assisted psychotherapy or esketamine nasal treatment. Psilocybin and MDMA are not available as routine approved treatments in Illinois; research participation requires separate screening and does not mean a clinic can offer them commercially. Read each Chicago profile on this page to see which of those ketamine-based services it actually provides.
Chicago options extend across the Loop, West Loop, Lakeview and Wicker Park, with suburban services in Oak Brook and Naperville. For western suburban patients, the Eisenhower Expressway (I-290) and East-West Tollway (I-88) connect the city with that broader service area. Compare the actual dosing location and return trip, especially when follow up requires repeated travel. Confirm the exact office address before booking, since intake and treatment may happen at different locations.
In a typical first visit, a prescriber reviews psychiatric history, current medications and physical health, along with previous treatments and what the patient hopes will change. Ask whether licensed psychotherapy is built into the plan, who leads preparation and integration conversations, and how the office tracks symptoms and side effects afterward. Ketamine infusion and ketamine-assisted psychotherapy are billed and structured differently, and not every Chicago office offers both. Ask who administers medication, who monitors you throughout the appointment and what transportation arrangements the office requires afterward.
Before booking, ask about the prescriber's credentials and supervision on site, exactly what medication is used and where it comes from, and how risks and side effects are disclosed in writing. Ask what happens if treatment does not help, and request an itemized quote separating evaluation, medication, monitoring and psychotherapy, since much of this care is cash pay. Ketamine is not FDA approved for psychiatric conditions, while esketamine has specific approved depression uses; evidence for other requested uses can be limited. The national psychedelic therapy hub explains mechanisms and evidence in more depth.
Organic listing order is not sold. Featured placements are labeled and capped, Verified means credential checks rather than spending, and Regenerated.com is free for patients. Inclusion in the directory is not an endorsement of any provider. For help comparing entries, read How to read a Regenerated city hub and Featured vs Verified vs organic.
Regulatory context
Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.
Illinois enforces federal scheduling. The Illinois Department of Financial and Professional Regulation (IDFPR) oversees prescriber conduct. DEA enforcement on ketamine clinics focuses on diversion and Ryan Haight Act telehealth rules. Illinois PMP requires controlled substance reporting. Active legislative interest (CURE Act) has drawn regulatory attention but no current therapeutic access framework exists.
Explore nearby
Available here
Explore statewide
Psychedelic Therapy in IllinoisNationwide
Psychedelic Therapy clinics across the US